INTEGRA LIFESCIENCES HOLDINGS CORP (IART) › Capital ExpendituresINTEGRA LIFESCIENCES HOLDINGS CORP (IART) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2008: $13.40M2009: $25.24M2010: $37.14M2011: $38.42M2012: $69.03M2013: $42.30M2014: $38.34M2015: $33.41M2016: $47.33M2017: $43.50M2018: $77.74M2019: $69.54M2020: $38.89M2021: $48.02M2022: $42.34M2023: $66.86M2024: $104.42M2025: $81.44M$81.44M2008Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$81.44M-22.0%2024$104.42M+56.2%2023$66.86M+57.9%2022$42.34M-11.8%2021$48.02M+23.5%2020$38.89M-44.1%2019$69.54M-10.6%2018$77.74M+78.7%2017$43.50M-8.1%2016$47.33M+41.6%2015$33.41M-12.9%2014$38.34M-9.4%2013$42.30M-38.7%2012$69.03M+79.7%2011$38.42M+3.5%2010$37.14M+47.2%2009$25.24M+88.3%2008$13.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share